Nissan Chemical Corporation (4021)

Name: Nissan Chemical Corporation (4021) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Basic Materials · Wall Street (EE. UU.) · Última actualización: 2026-10-02

Nissan Chemical Corporation engages in the chemicals, performance materials, agricultural chemicals, and healthcare businesses in Japan and internationally.

Cifras clave

Capitalización bursátil: JPY 1.12 trillion
Ingresos (ejercicio cerrado en 2026-03-31): JPY 279.6B
Beneficio neto: JPY 49.7B
Margen bruto: 46.8%
Margen neto: 17.8%

Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →

Cuenta de resultados anual

Cuenta de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Ingresos totales	JPY 279.6B	JPY 251.4B	JPY 226.7B	JPY 228.1B
Beneficio bruto	JPY 130.9B	JPY 116.5B	JPY 104.8B	JPY 106.8B
Ingresos operativos (EBIT)	JPY 63.6B	JPY 56.8B	JPY 48.2B	JPY 52.3B
Ingresos netos	JPY 49.7B	JPY 43.0B	JPY 38.0B	JPY 41.1B

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de 4021. /companies/us/4021

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.